M3 expands with acquisition of Vidal Group
M3, the healthcare services provider, has expanded its global operations with the acquisition of healthcare informatics firm Vidal Group. In a move to complement its existing business activities across the UK, US and Asia, M3 is now set to support the growth of Vidal's services focusing on key markets in Europe and Latin America. Vidal Group currently specialises in providing reference drug information for healthcare professionals, with online databases tailored to cover all the latest treatment information and medical advances. Now part of the M3 network - which includes M3.com, MDLinx, Medigate, medlive.cn, M3Medical and Doctors.net.uk - the group will also offer market research, digital communications and clinical trials and recruitment services. Aki Tomaru, board director and chief executive of M3 USA, said:
Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!
